Canopus Biopharma Incorporated Stock Probability of Future Pink Sheet Price Finishing Over 40.29
| CBIA Stock | USD 0.0001 0.00 0.00% |
Canopus |
Canopus BioPharma Target Price Odds to finish over 40.29
The tendency of Canopus Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 40.29 or more in 90 days |
| 0.0001 | 90 days | 40.29 | close to zero percent |
Based on a normal probability distribution, the odds of Canopus BioPharma to move over $ 40.29 or more in 90 days from now is close to zero percent (This Canopus BioPharma Incorporated probability density function shows the probability of Canopus Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Canopus BioPharma price to stay between its current price of $ 0.0001 and $ 40.29 at the end of the 90-day period is close to zero percent.
Given the investment horizon of 90 days Canopus BioPharma has a beta of 0.51 suggesting as returns on the market go up, Canopus BioPharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Canopus BioPharma Incorporated will be expected to be much smaller as well. In addition to that Canopus BioPharma Incorporated has an alpha of 6.0567, implying that it can generate a 6.06 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Canopus BioPharma Price Density |
| Price |
Predictive Modules for Canopus BioPharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Canopus BioPharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Canopus BioPharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Canopus BioPharma is not an exception. The market had few large corrections towards the Canopus BioPharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Canopus BioPharma Incorporated, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Canopus BioPharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 6.06 | |
β | Beta against Dow Jones | 0.51 | |
σ | Overall volatility | 0.000048 | |
Ir | Information ratio | 0.15 |
Canopus BioPharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Canopus BioPharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Canopus BioPharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Canopus BioPharma is way too risky over 90 days horizon | |
| Canopus BioPharma has some characteristics of a very speculative penny stock | |
| Canopus BioPharma appears to be risky and price may revert if volatility continues | |
| Latest headline from kalkinemedia.com: Marine Environmental Protection Alliance Announces Leadership Appointment, Reaffirms Commitment to Ocean Conservation |
Canopus BioPharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Canopus Pink Sheet often depends not only on the future outlook of the current and potential Canopus BioPharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Canopus BioPharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Short Long Term Debt | 1.9 M |
Canopus BioPharma Technical Analysis
Canopus BioPharma's future price can be derived by breaking down and analyzing its technical indicators over time. Canopus Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Canopus BioPharma Incorporated. In general, you should focus on analyzing Canopus Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Canopus BioPharma Predictive Forecast Models
Canopus BioPharma's time-series forecasting models is one of many Canopus BioPharma's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Canopus BioPharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Canopus BioPharma
Checking the ongoing alerts about Canopus BioPharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Canopus BioPharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Canopus BioPharma is way too risky over 90 days horizon | |
| Canopus BioPharma has some characteristics of a very speculative penny stock | |
| Canopus BioPharma appears to be risky and price may revert if volatility continues | |
| Latest headline from kalkinemedia.com: Marine Environmental Protection Alliance Announces Leadership Appointment, Reaffirms Commitment to Ocean Conservation |
Other Information on Investing in Canopus Pink Sheet
Canopus BioPharma financial ratios help investors to determine whether Canopus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Canopus with respect to the benefits of owning Canopus BioPharma security.